Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹353.70
Market cap: ₹2,166 Cr
Revenue (annual): ₹639.8 Cr
Net profit (annual): ₹-5.38 Cr
P/E (TTM): -304.3×Sector 43.8×
Promoter holding: 72.48%+0.00% QoQ
FII holding: 2.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 9 Other Announcement 5 Promoter Buying (Off-Market) 3 New Order Win 3 Financial Results 3 Board Meeting Date 3 Annual General Meeting 2 Management Change 1 Capital Structure Change 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

31 announcements with these filters

7 Apr 2026 11:48 IST BSE

Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec Limited received a rectified Assessment Order from the Income Tax department for AY 2015-16. The rectification successfully nullifies a previous tax demand of approximately ₹45.71 Crore, resulting in Nil tax liability. This correction of errors regarding disallowances and losses provides a significant positive financial impact for the company.

Value: ₹45.71 Cr

Open announcement → Read the filing ↗